Form 8-K - Current report:
SEC Accession No. 0001104659-21-054910
Filing Date
2021-04-26
Accepted
2021-04-26 16:11:59
Documents
3
Period of Report
2021-04-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2114180-1_8k.htm 8-K 17122
2 EXHIBIT 99.1 tm2114180d1_ex99-1.htm EX-99.1 9548
3 GRAPHIC image_001.jpg GRAPHIC 67481
  Complete submission text file 0001104659-21-054910.txt   121005
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 21853938
SIC: 2834 Pharmaceutical Preparations